Skip to main navigationSkip to main content
The University of Southampton
We're launching a new website soon and would love your feedback. See the new design

Research project: ATTACK: Aspirin to target arterial events in Chronic Kidney Disease

Currently Active: 

Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?

This multicentre randomised trial will assess the effectiveness of low dose aspirin to prevent cardiovascular disease (CVD) in adult patients with chronic kidney disease(CKD). There is uncertainty about the benefits (vs CVD) and harms (bleeding) of aspirin in such patients. CKD is common and the frequency is rising and it is associated with increased risk of CVD.

Local Investigators: Roderick P, Moore M, Lord J, Maishman T, Mark Lown

Study team: CI Gallagher H (Epsom and St Helier University Hospital),  Dumbleton J (Nottingham University), Anson-Wisniewsksa K (Southampton)

Funder: NIHR HTA, British Heart Foundation

Duration: Start date 2018  End date 2025




Related research groups

Primary Care, Population Sciences and Medical Education
Population Health Sciences Research group

Key Publication

Share this research project Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings